New scar gel aims to outperform current treatments in 90-Day trial

NCT ID NCT06751433

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tests a scar gel against a leading product to see which better prevents raised scars and improves scar appearance, hydration, and color. Eighty adults with recent scars (from C-sections, breast implants, or cuts) will use the gel daily for 90 days. Doctors and participants will rate the results using standard scales and questionnaires.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
scar gel
What this could lead to
If successful, this could provide a safe and effective option for improving the appearance and feel of new scars.
What could go wrong
This is an early-phase study with only 80 participants, so results may not apply to everyone. The gel may not work better than existing products.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACCEPTABILITY STUDY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Cicatrix, Hypertrophic keloid

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • MEDCIN

    RECRUITING

    Osasco, Brazil

  • Medcin Instituto da Pele Ltda

    NOT_YET_RECRUITING

    Osasco, São Paulo, Brazil

More trials for these conditions

Other studies related to the condition(s) this trial covers.